A judge acquitted three doctors, a New Jersey company and a former Red Cross official of criminal charges Monday in a tainted-blood scandal that infected thousands of Canadians with HIV or hepatitis and resulted in more than 3,000 deaths.
Ontario superior court justice Mary Lou Benotto ruled that the defendants did not show conduct displaying wanton and reckless disregard in the use of the blood and that there was no marked departure from the standards of a reasonable person.
''The conduct examined in detail over one and a half years confirms reasonable and responsible and professional actions and responses during this difficult time,'' she said. ''The allegations of criminal conduct on the part of these men and this corporation were not only unsupported by the evidence, they were disproved.
''The events here were tragic,'' the judge said. ''However, to assign blame where none exists is to compound the tragedy.''
James Kreppner, a Toronto lawyer who contracted HIV and hepatitis C from the tainted blood, said he was astounded.
''It was clearly negligent behavior and a company violated its statutory duty, and to call that professional conduct, you just can't justify that,'' he said.
John Plater of the Canadian Hemophilia Society expressed bewilderment at the verdict. ''If you, on the one hand, have a study that says there's a problem and on the other hand have a study that says maybe there isn't a problem, any reasonable person takes the product off the market. They didn't. People were infected, and people died,'' Plater said. ''How that could be considered reasonable behavior is beyond us.''
The case involved blood products produced by New Jersey–based Armour Pharmaceutical Co. in the 1980s and early 1990s that turned out to be infected. Also charged were Roger Perrault of the Red Cross; John Furesz and Donald Wark Boucher, formerly of Canada's Health Protection Branch, and Michael Rodell, a former vice president of Armour.
Perrault pleaded not guilty to criminal negligence causing bodily harm for allegedly giving hemophilia patients an HIV-infected blood-clotting product.
The other doctors and the drug company also pleaded not guilty. Lawyers argued that prosecutors didn't present enough evidence to prove its case.
Defense attorney Edward Greenspan called it a complete exoneration of his clients Perrault and Armour Pharmaceutical.
''Canada was well-served by the people that made these decisions. They did everything in their power to make the right decision. They acted upon the information they knew at the time,'' he said.
A second trial for Perrault is set to begin later this year in Hamilton, Ontario, where he will face more criminal charges stemming from allegations that the Red Cross and its senior officials failed to take adequate measures to screen blood donors.
Mina Shah, who lost her 24-year-old brother Karttik Shah to AIDS and hepatitis as a result of the tainted blood, said she couldn't accept the decision.
''She said it was OK and a great job was done. That doesn't sit well,'' Shah said of the judge's decision. ''There should have been some sort of punishment.''
The Canadian Red Cross pleaded guilty in 2005 to distributing blood tainted with HIV and hepatitis C and was fined 5,000 Canadian dollars, which is now about $5,000 U.S. The Red Cross apologized and provided 1.5 million Canadian dollars for a scholarship fund and research project aimed at reducing medical errors.
Responsibility for Canada's blood supply for all provinces except Quebec was later transferred from the Canadian Red Cross to another entity, Canadian Blood Services. After a five-year investigation, police filed criminal charges.
Last year the Canadian government announced a compensation package of about $1 billion for all those infected with hepatitis C from the tainted blood, expanding a previous program that excluded thousands of people. (AP)
These comments are reproduced as written by visitors to this Web site. They have not been edited for content, grammar, or spelling. The viewpoints appearing here are those of the writer, and do not necessarily reflect the opinion or views of advocate.com, The Advocate, or its affiliates.
Be the first to comment on this story.
If you would like to submit a comment for posting, please fill out the form above.
All comments submitted via this form are subject to posting or publication. (To send a private letter to an Advocate editor or writer, please use the e-mail button at the top of the page, or use snail mail.) If you would like your comment considered for publication in The Advocate magazine, please include your full name, your city of residence, and a phone number where you can be reached during business hours so that we can confirm your identity. Your e-mail address and telephone number are strictly confidential and will not be shared or used for any purpose other than to contact you about your comment.
See the Contact page for sending comments for reasons other than responding to Advocate editorial and news stories.
Please note that comments sent by fax or snail mail are unlikely to be posted, although they will be considered for publication along with all letters received via e-mail or via this Web page. Comments that chiefly concern Advocate.com content will be considered for posting only on the Web site. The Advocate reserves the right to edit submitted comments for grammar, spelling, obscenities, or libel; we will, however, do our best to preserve the original comment's style and intent. Comments considered for publication in The Advocate magazine may also be edited for length.
Home | Contact | Current Issue | LGBT Community Partners | Staff
Jobs | Help
Subscribe: Print Edition Digital Edition | Subscriber Services: Print Edition Digital Edition
Visit our Websites
Out.com | OutTraveler.com | HIVPlusMag.com | Alyson.com | HereTV.com | GayWired.com | SheWired.com
Privacy Policy | User Agreement | Community Guidelines | Legal Notice
Advocate.com © 2009 Regent Entertainment Media Inc. All Rights Reserved.
